Trial intelligence / Profile preview

Olanzapine vs aprepitant + Kytril vs granisetron for chemotherapy-induced nausea and vomiting

IRCT20190217042735N1Phase 3Completed

Sponsor
Zahedan University of Medical Sciences
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Nausea and Vomiting comparing Olanzapine, Aprepitant + Kytril and Granisetron (3 arms). Started Jul 2019; status: completed.

02

Drugs

olanzapineaprepitantgranisetron
03

Conditions

Nausea and Vomiting

Beyond the preview

Go deeper on IRCT20190217042735N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190217042735N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call